GHRH analogue
A growth-hormone-releasing hormone analogue.
Sermorelin has an established pharmacology as a GHRH analogue and a historical diagnostic and therapeutic role. Evidence for general "anti-ageing" or performance use is limited and not an approved indication.
Under medical supervision, side effects are typically injection-site reactions, flushing or headache. Used without oversight or sourced from unregulated suppliers, the risks rise sharply.
Available in Australia only via a prescription from a registered doctor, often dispensed through a compounding pharmacy.
A prescription-only pathway exists: a registered doctor may prescribe it, frequently via a compounding pharmacy. It is not an over-the-counter or online-checkout product.
A registered doctor can prescribe it where clinically appropriate, often through a compounding pharmacy. Any legitimate access involves a genuine consultation, not a no-prescription purchase.
This entry is general information about Sermorelin, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.